Literature DB >> 17055488

The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I.

Byoung Boo Seo1, Mathieu Marella, Takao Yagi, Akemi Matsuno-Yagi.   

Abstract

Using rat dopaminergic and human neuroblastoma cell lines transduced with the NDI1 gene encoding the internal NADH dehydrogenase (Ndi1) from Saccharomyces cerevisiae, we investigated reactive oxygen species (ROS) generation caused by complex I inhibition. Incubation of non-transduced cells with rotenone elicited oxidative damage to mitochondrial DNA as well as lipid peroxidation. In contrast, oxidative stress was significantly decreased when the cells were transduced with NDI1. Furthermore, mitochondria from the NDI1-transduced cells showed a suppressed rate of ROS formation by the complex I inhibitors. We conclude that the Ndi1 enzyme is able to suppress ROS overproduction from defective complex I.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055488     DOI: 10.1016/j.febslet.2006.10.008

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS.

Authors:  Venu Talla; Hong Yu; Tsung-Han Chou; Vittorio Porciatti; Vince Chiodo; Sanford L Boye; William W Hauswirth; Alfred S Lewin; John Guy
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

2.  LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.

Authors:  Yulia Y Tyurina; Daniel E Winnica; Valentina I Kapralova; Alexandr A Kapralov; Vladimir A Tyurin; Valerian E Kagan
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

Review 3.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 4.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

Review 5.  Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

Authors:  Mathieu Marella; Byoung Boo Seo; Takao Yagi; Akemi Matsuno-Yagi
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

6.  Neuronal expression of a single-subunit yeast NADH-ubiquinone oxidoreductase (Ndi1) extends Drosophila lifespan.

Authors:  Sepehr Bahadorani; Jaehyoung Cho; Thomas Lo; Heidy Contreras; Hakeem O Lawal; David E Krantz; Timothy J Bradley; David W Walker
Journal:  Aging Cell       Date:  2010-04       Impact factor: 9.304

Review 7.  AIF, reactive oxygen species, and neurodegeneration: a "complex" problem.

Authors:  Brian M Polster
Journal:  Neurochem Int       Date:  2012-12-12       Impact factor: 3.921

8.  Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model.

Authors:  Mathieu Marella; Byoung Boo Seo; Biju B Thomas; Akemi Matsuno-Yagi; Takao Yagi
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

9.  RACK1/Asc1p, a ribosomal node in cellular signaling.

Authors:  Nicole Rachfall; Kerstin Schmitt; Susanne Bandau; Nadine Smolinski; Armin Ehrenreich; Oliver Valerius; Gerhard H Braus
Journal:  Mol Cell Proteomics       Date:  2012-10-15       Impact factor: 5.911

10.  Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.

Authors:  Robert M Mentzer; Joseph Wider; Cynthia N Perry; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-12-23       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.